PROCEPT BioRobotics Corporation
PRCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,988,897 | $3,193,632 | $3,199,464 | $4,335,036 |
| - Cash | $294,281 | $302,717 | $316,207 | $333,725 |
| + Debt | $78,926 | $79,367 | $81,813 | $80,250 |
| Enterprise Value | $1,773,542 | $2,970,282 | $2,965,070 | $4,081,561 |
| Revenue | $83,327 | $79,182 | $69,162 | $68,236 |
| % Growth | 5.2% | 14.5% | 1.4% | – |
| Gross Profit | $54,006 | $51,746 | $44,161 | $43,672 |
| % Margin | 64.8% | 65.4% | 63.9% | 64% |
| EBITDA | -$18,874 | -$17,095 | -$22,385 | -$16,434 |
| % Margin | -22.7% | -21.6% | -32.4% | -24.1% |
| Net Income | -$21,411 | -$19,578 | -$24,737 | -$18,856 |
| % Margin | -25.7% | -24.7% | -35.8% | -27.6% |
| EPS Diluted | -0.38 | -0.35 | -0.45 | -0.35 |
| % Growth | -8.6% | 22.2% | -28.6% | – |
| Operating Cash Flow | -$6,635 | -$15,043 | -$16,980 | -$32,391 |
| Capital Expenditures | -$2,868 | -$2,802 | -$1,836 | -$1,174 |
| Free Cash Flow | -$9,503 | -$17,845 | -$18,816 | -$33,565 |